{"id":"https://openalex.org/W2147677141","doi":null,"title":"Metabotrobic Glutamate Receptor mGluR4 as a Novel Target for Parkinson's Disease","display_name":"Metabotrobic Glutamate Receptor mGluR4 as a Novel Target for Parkinson's Disease","publication_year":1999,"publication_date":"1999-10-01","ids":{"openalex":"https://openalex.org/W2147677141","mag":"2147677141"},"language":"en","primary_location":{"id":"pmh:ADA371971","doi":null,"is_oa":false,"landing_page_url":"http://oai.dtic.mil/oai/oai?&verb=getRecord&metadataPrefix=html&identifier=ADA371971","pdf_url":null,"source":{"id":"https://openalex.org/S4406923043","display_name":"Defense Technical Information Center (DTIC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"DTIC AND NTIS","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018660787","display_name":"Allan I Levy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Allan I Levy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5018660787"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.5562000274658203,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.5562000274658203,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.37400001287460327,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.048900000751018524,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9210000038146973},{"id":"https://openalex.org/keywords/basal-ganglia","display_name":"basal ganglia","score":0.953000009059906},{"id":"https://openalex.org/keywords/substantia-nigra-pars-reticulata","display_name":"substantia nigra pars reticulata","score":0.8769999742507935},{"id":"https://openalex.org/keywords/subthalamic-nucleus","display_name":"subthalamic nucleus","score":0.9139999747276306},{"id":"https://openalex.org/keywords/presynaptic-inhibition","display_name":"presynaptic inhibition","score":0.8690000176429749},{"id":"https://openalex.org/keywords/group-iii-mglurs","display_name":"group III mGluRs","score":0.7760000228881836},{"id":"https://openalex.org/keywords/group-ii-mglurs","display_name":"group II mGluRs","score":0.9739999771118164},{"id":"https://openalex.org/keywords/ly354740","display_name":"LY354740","score":0.9729999899864197},{"id":"https://openalex.org/keywords/catalepsy","display_name":"catalepsy","score":0.9160000085830688},{"id":"https://openalex.org/keywords/glutamate-receptor-agonists","display_name":"glutamate receptor agonists","score":0.5},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.37599998712539673}],"concepts":[{"id":"https://openalex.org/C49051014","wikidata":"https://www.wikidata.org/wiki/Q2033959","display_name":"Metabotropic glutamate receptor","level":4,"score":0.7927209138870239},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.7515527009963989},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.5145999193191528},{"id":"https://openalex.org/C2780278869","wikidata":"https://www.wikidata.org/wiki/Q1759633","display_name":"Globus pallidus","level":4,"score":0.5020408630371094},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.48795264959335327},{"id":"https://openalex.org/C2778187257","wikidata":"https://www.wikidata.org/wiki/Q464210","display_name":"Basal ganglia","level":3,"score":0.4801304042339325},{"id":"https://openalex.org/C207951395","wikidata":"https://www.wikidata.org/wiki/Q288431","display_name":"Metabotropic glutamate receptor 1","level":5,"score":0.43229788541793823},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.4127841889858246},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3487963378429413},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.3404316306114197},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32798898220062256},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28849488496780396},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.27345675230026245},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.17112582921981812},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14478525519371033},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1125703752040863}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:ADA371971","doi":null,"is_oa":false,"landing_page_url":"http://oai.dtic.mil/oai/oai?&verb=getRecord&metadataPrefix=html&identifier=ADA371971","pdf_url":null,"source":{"id":"https://openalex.org/S4406923043","display_name":"Defense Technical Information Center (DTIC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"DTIC AND NTIS","raw_type":"Text"},{"id":"mag:2147677141","doi":null,"is_oa":false,"landing_page_url":"https://apps.dtic.mil/docs/citations/ADA371971","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":66,"referenced_works":["https://openalex.org/W1239299315","https://openalex.org/W1483198065","https://openalex.org/W1487123995","https://openalex.org/W1510554078","https://openalex.org/W1526327880","https://openalex.org/W1548031896","https://openalex.org/W1595843790","https://openalex.org/W1614343476","https://openalex.org/W1756742701","https://openalex.org/W1768450208","https://openalex.org/W1926939570","https://openalex.org/W1970533983","https://openalex.org/W1974366641","https://openalex.org/W1983108892","https://openalex.org/W1983664266","https://openalex.org/W1984393517","https://openalex.org/W1986077377","https://openalex.org/W1989123260","https://openalex.org/W1990280414","https://openalex.org/W1991806665","https://openalex.org/W1993068285","https://openalex.org/W1993407150","https://openalex.org/W1996942781","https://openalex.org/W2000609428","https://openalex.org/W2001744744","https://openalex.org/W2005362819","https://openalex.org/W2007051067","https://openalex.org/W2015778209","https://openalex.org/W2022072305","https://openalex.org/W2022907828","https://openalex.org/W2029542833","https://openalex.org/W2039937066","https://openalex.org/W2042466545","https://openalex.org/W2047575016","https://openalex.org/W2050620515","https://openalex.org/W2057259149","https://openalex.org/W2058591676","https://openalex.org/W2059387706","https://openalex.org/W2060588252","https://openalex.org/W2061087008","https://openalex.org/W2061522482","https://openalex.org/W2070503276","https://openalex.org/W2072818925","https://openalex.org/W2074307342","https://openalex.org/W2074402500","https://openalex.org/W2077493915","https://openalex.org/W2081234982","https://openalex.org/W2083978441","https://openalex.org/W2086894916","https://openalex.org/W2089271111","https://openalex.org/W2098150710","https://openalex.org/W2099859528","https://openalex.org/W2106042714","https://openalex.org/W2131697380","https://openalex.org/W2140142911","https://openalex.org/W2142009737","https://openalex.org/W2146112646","https://openalex.org/W2147428924","https://openalex.org/W2148486363","https://openalex.org/W2157450061","https://openalex.org/W2161011774","https://openalex.org/W2165618729","https://openalex.org/W2259214560","https://openalex.org/W2288785867","https://openalex.org/W2310459878","https://openalex.org/W2311816167"],"related_works":["https://openalex.org/W7020801165","https://openalex.org/W1965697123","https://openalex.org/W2748295718","https://openalex.org/W1645547702","https://openalex.org/W2014553622","https://openalex.org/W2367087974","https://openalex.org/W2088947382","https://openalex.org/W7095244191","https://openalex.org/W1985423204","https://openalex.org/W1991202463"],"abstract_inverted_index":{"The":[0],"symptoms":[1,97],"of":[2,11,19,21,36,48,68,79,90,145,161,173,193],"Parkinson's":[3],"disease":[4],"(PD)":[5],"are":[6,53,107],"associated":[7],"with":[8],"a":[9,42,116,142],"loss":[10],"substantia":[12],"nigra":[13],"dopaminergic":[14],"neurons":[15],"involved":[16],"in":[17,32,57,74,81,94,98,118,121,147,157,175],"modulation":[18],"function":[20],"the":[22,34,46,66,76,88,122,132,148,168,176,179],"basal":[23,61],"ganglia":[24,62],"(BG)":[25],".":[26],"This":[27],"report":[28],"describes":[29],"our":[30,51],"progress":[31],"understanding":[33],"role":[35,67],"metabotropic":[37],"glutamate":[38,80],"receptors":[39,183],"(mGluRs)":[40],"as":[41,164],"novel":[43,188],"target":[44],"for":[45,187,191],"treatment":[47,192],"PD.":[49,162],"Specifically,":[50],"aims":[52],"to":[54,64,86,140],"localize":[55],"mGluR4":[56],"rat":[58,82],"and":[59,85,112,150,170,195],"monkey":[60],"structures,":[63],"determine":[65,87],"this":[69],"receptor":[70],"vs.":[71],"other":[72],"subtypes":[73],"mediating":[75],"electrophysiological":[77],"effects":[78],"brain":[83],"slices,":[84],"efficacy":[89],"drugs":[91],"aimed":[92],"mGluRs":[93,106,126,137,174],"relieving":[95],"motor":[96],"hemi-parkinsonian":[99],"monkeys.":[100],"We":[101],"found":[102,139],"that":[103,113,181],"group":[104,151],"III":[105,125],"presynaptic":[108,143],"on":[109],"striatal-pallidal":[110],"terminals":[111],"they":[114],"mediate":[115,141],"reduction":[117,144],"IPSC":[119],"amplitude":[120],"SNr.":[123],"Group":[124,135],"also":[127],"presynaptically":[128],"inhibit":[129],"EPSCs":[130,146],"at":[131],"STN-SNr":[133],"synapse.":[134],"II":[136,152],"were":[138],"SNr":[149],"agonist":[153],"LY354740":[154],"reverses":[155],"catalepsy":[156],"an":[158],"animal":[159],"model":[160],"Furthermore,":[163],"these":[165,182],"studies":[166],"progress,":[167],"distribution":[169],"physiological":[171],"roles":[172],"BG":[177],"raises":[178],"possibility":[180],"may":[184],"provide":[185],"targets":[186],"therapeutic":[189],"agents":[190],"PD":[194],"related":[196],"disorders.":[197]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}